United States

People: Abiomed Inc (ABMD.O)

ABMD.O on Nasdaq

12:39pm EDT
Change (% chg)

$1.83 (+1.17%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Minogue, Michael 

Mr. Michael R. Minogue is the Chairman of the Board, President, Chief Executive Officer of Abiomed, Inc. He has served as our Chief Executive Officer, President and a director since April 2004. In June 2005, he was appointed Chairman of our Board of Directors. Prior to joining us, Mr. Minogue had a twelve-year career at General Electric, or GE. Most recently, Mr. Minogue was Vice President and General Manager of Americas Sales and Marketing for GE Medical Systems Information Technology. From 1997 to 2004, Mr. Minogue held various positions at GE, including General Manager for the Global Positron Emission Technology Business, General Manager, Americas Cardiology & IT Sales and General Manager, Global Installed Base. Prior to joining GE, Mr. Minogue served on active duty for four years as an infantry officer in the U.S. Army and received multiple awards. Mr. Minogue received his Bachelor of Science in Engineering Management from the United States Military Academy at West Point and his Master of Business Administration from the University of Chicago. Mr. Minogue currently serves on the Board of Directors of the Advanced Medical Technology Association and also serves as a Manager on the Board of Managers of Bioventus LLC, a strategic partnership between EW Healthcare Partners and Smith & Nephew plc, a global medical technology business based in the United Kingdom. Mr. Minogue is also the Chair of the Board of Directors of the Medical Device Innovation Consortium, a public-private partnership created with the objective of advancing medical device regulatory science. He was formerly on the Board of Directors of LifeCell Corporation, which was acquired by Kinetic Concepts, Inc. in May 2008.

Basic Compensation

Total Annual Compensation, USD 648,748
Restricted Stock Awards, USD 9,405,480
Long-Term Incentive Plans, USD --
All Other, USD 2,165,110
Fiscal Year Total, USD 12,219,300

Options Compensation

  Quantity Market Value
Exercisable 100,000 385,000.00
Unexercisable 400,000 1,509,000.00
Exercised 91,783 11,658,700.00
Name Fiscal Year Total

Michael Minogue


Ian McLeod


David Weber


William Bolt


Andrew Greenfield


Michael Howley

As Of  30 Mar 2017